Articles 1 - 1 of 1
Full-Text Articles in Molecular Biology
Actinomycin D And Telmisartan Combination Therapy Targets Lung Cancer Stem Cells, Ryan Green
Graduate Theses and Dissertations
The failure of lung cancer treatments has been attributed partly to the development of drug resistance, however the underlying cellular and molecular mechanisms are poorly understood. It has been suggested that a very small group of specific cells within the heterogeneous tumors, cancer initiating stem cells (CSC), develop resistance to treatment, survive and later initiate the growth of new tumors. Due to their pivotal role in maintenance and relapse of tumors following the acquisition of drug resistance, we reasoned that novel drugs targeting cancer cells and CSC might provide the most effective treatments, if not a cure. To this end ...